Innovative public strategies in response to COVID-19: A review of practices from China
- PMID: 39735280
- PMCID: PMC11671218
- DOI: 10.1002/hcs2.122
Innovative public strategies in response to COVID-19: A review of practices from China
Abstract
The COVID-19 pandemic presented unparalleled challenges to prompt and adaptive responses from nations worldwide. This review examines China's multifaceted approach to the crisis, focusing on five key areas of response: infrastructure and system design, medical care and treatment, disease prevention and control, economic and social resilience, and China's engagement in global health. This review demonstrates the effectiveness of a top-down command system at the national level, intersectoral coordination, a legal framework, and public social governance. This study also examines medical care and treatment strategies, highlighting the importance of rapid emergency response, evidence-based treatment, and well-planned vaccination rollout. Further discussion on disease prevention and control measures emphasizes the importance of adaptive measures, timely infection control, transmission interruption, population herd immunity, and technology applications. Socioeconomic impact was also assessed, detailing strategies for disease prevention, material supply, livelihood preservation, and social economy revival. Lastly, we examine China's contributions to the global health community, with a focus on knowledge-sharing, information exchange, and multilateral assistance. While it is true that each nation's response must be tailored to its own context, there are universal lessons to be drawn from China's approach. These insights are pivotal for enhancing global health security, especially as the world navigates evolving health crises.
Keywords: COVID‐19; emergency response; health care management; pandemic.
© 2024 The Author(s). Health Care Science published by John Wiley & Sons, Ltd on behalf of Tsinghua University Press.
Conflict of interest statement
Professor Zongjiu Zhang is the member of the Health Care Science Editorial Board. To minimize bias, he was excluded from all editorial decision‐making related to the acceptance of this article for publication. The remaining authors declare no conflict of interest.
Figures






Similar articles
-
China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.Front Public Health. 2021 Dec 15;9:756677. doi: 10.3389/fpubh.2021.756677. eCollection 2021. Front Public Health. 2021. PMID: 34976920 Free PMC article.
-
Advancing knowledge of One Health in China: lessons for One Health from China's dengue control and prevention programs.Sci One Health. 2024 Nov 8;3:100087. doi: 10.1016/j.soh.2024.100087. eCollection 2024. Sci One Health. 2024. PMID: 39641122 Free PMC article. Review.
-
Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.J Med Internet Res. 2021 Jun 17;23(6):e27345. doi: 10.2196/27345. J Med Internet Res. 2021. PMID: 34061761 Free PMC article.
-
China's COVID-19 Control Strategy and Its Impact on the Global Pandemic.Front Public Health. 2022 Mar 14;10:857003. doi: 10.3389/fpubh.2022.857003. eCollection 2022. Front Public Health. 2022. PMID: 35359767 Free PMC article.
-
Lessons Learned From the Resilience of Chinese Hospitals to the COVID-19 Pandemic: Scoping Review.JMIRx Med. 2022 Apr 6;3(2):e31272. doi: 10.2196/31272. eCollection 2022 Apr-Jun. JMIRx Med. 2022. PMID: 35435649 Free PMC article.
Cited by
-
Melatonin from Plants: Going Beyond Traditional Central Nervous System Targeting-A Comprehensive Review of Its Unusual Health Benefits.Biology (Basel). 2025 Jan 30;14(2):143. doi: 10.3390/biology14020143. Biology (Basel). 2025. PMID: 40001911 Free PMC article. Review.
-
Reflecting on Achievements and Renewing Our Vision.Health Care Sci. 2025 Jan 28;4(1):1-3. doi: 10.1002/hcs2.127. eCollection 2025 Feb. Health Care Sci. 2025. PMID: 40026639 Free PMC article. No abstract available.
References
-
- COVID‐19 strategic preparedness and response plan: Monitoring and evaluation framework. Geneva: World Health Organization; 2021. (WHO/WHE/2021.07). Contract No.: CC BY‐NC‐SA 3.0 IGO.
Publication types
LinkOut - more resources
Full Text Sources